Upgrade to Chrome Upgrade to Firefox Upgrade to Microsoft Edge Upgrade to Safari
Skip to content
  • Services
    • Overview
    • Global Market Access
    • Evidence Review & Synthesis
    • Health Economic Modelling
    • Health Technology Assessment
    • Data Science & Analytics
    • Value Communication
    • Overview
    • Global Market Access
    • Evidence Review & Synthesis
    • Health Economic Modelling
    • Health Technology Assessment
    • Data Science & Analytics
    • Value Communication
    • Global Market Access
    • Evidence Review & Synthesis
    • Health Economic Modelling
    • Health Technology Assessment
    • Data Science & Analytics
    • Value Communication
  • About
    • About HEOR
    • Our Ethos
    • Team
    • Case Studies
    • About HEOR
    • Our Ethos
    • Team
    • Case Studies
    • About HEOR
    • Our Ethos
    • Team
    • Case Studies
  • Insights
    • Industry Insights
    • News
    • Publications
    • Industry Insights
    • News
    • Publications
    • Insights
    • News
    • Publications
  • Join us
    • Our people
    • Learn & develop
    • Candidate journey
    • Latest vacancies
    • Our people
    • Learn & develop
    • Candidate journey
    • Latest vacancies
    • Our people
    • Learn & develop
    • Candidate journey
    • Latest vacancies
  • Contact

International clinical consensus on leukocyte adhesion deficiency-I: Modified Delphi analysis

Modified Delphi

Addressing the risk of ocular complications of GLP-1RAs; a multi-disciplinary expert consensus

Exploring a Patient-Centered Methodology to Identify Suitable Proxy Conditions as a Source for Utility Data, Using Alopecia Areata as a Case Example

Proxy conditions

Exploring a Patient-Centered Methodology to Identify Suitable Proxy Conditions as a Source for Utility Data, Using Alopecia Areata as a Case Example

Virologic response to dolutegravir plus lamivudine in people with suppressed human immunodeficiency virus type 1 and historical M184V/I: a systematic literature review and meta-analysis

Cabotegravir and rilpivirine long-acting antiretroviral therapy administered every 2 months is cost-effective for the treatment of HIV-1 in Spain

Comparative efficacy of advanced treatments in biologic-naïve or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis

Comparative efficacy and safety of fostemsavir in heavily treatment-experienced people with HIV-1

Cost-effectiveness and budget impact of dolutegravir/lamivudine for treatment of human immunodeficiency virus (HIV-1) infection in the United States

Cost-effectiveness of the long-acting regimen cabotegravir plus rilpivirine for the treatment of HIV-1 and its potential impact on adherence and viral transmission: a modelling study

Outcomes in rheumatoid arthritis patients treated with abatacept: a UK multi-centre observational study

Current challenges for assessing the long-term clinical benefit of cancer immunotherapy: a multi-stakeholder perspective

Next →
  • Services
  • Insights
  • Case studies
  • Services
  • Insights
  • Case studies
  • About us
  • Contact us
  • About us
  • Contact us
  • Privacy policy
  • Environmental policy
  • Privacy policy
  • Environmental policy
© 2026 Health Economics and Outcomes Research LTD, All Rights Reserved
GDPR verified badge
EcoVadis Committed badge for ESG performance
Carbon disclosure toolkit badge
Science Based Targets initiative (SBTi) validation logo

WE ARE COMMITTED TO SCIENCE-BASED CLIMATE TARGETS VALIDATED BY THE SBTI

  • Services
    • Global Market Access
    • Evidence Review & Synthesis
    • Health Economic Modelling
    • Health Technology Assessment
    • Data Science & Analytics
    • Value Communication
  • About
    • About HEOR
    • Our Ethos
    • Team
    • Case Studies
  • Insights
    • Insights
    • News
    • Publications
  • Join us
    • Our people
    • Learn & develop
    • Candidate journey
    • Latest vacancies
  • Contact